chr12-57564530-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004984.4(KIF5A):c.445+22A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.405 in 1,577,814 control chromosomes in the GnomAD database, including 137,947 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.43 ( 14309 hom., cov: 32)
Exomes 𝑓: 0.40 ( 123638 hom. )
Consequence
KIF5A
NM_004984.4 intron
NM_004984.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0400
Genes affected
KIF5A (HGNC:6323): (kinesin family member 5A) This gene encodes a member of the kinesin family of proteins. Members of this family are part of a multisubunit complex that functions as a microtubule motor in intracellular organelle transport. Mutations in this gene cause autosomal dominant spastic paraplegia 10. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 12-57564530-A-G is Benign according to our data. Variant chr12-57564530-A-G is described in ClinVar as [Benign]. Clinvar id is 682854.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.751 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KIF5A | NM_004984.4 | c.445+22A>G | intron_variant | ENST00000455537.7 | |||
KIF5A | NM_001354705.2 | c.178+22A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KIF5A | ENST00000455537.7 | c.445+22A>G | intron_variant | 1 | NM_004984.4 | P1 | |||
KIF5A | ENST00000286452.5 | c.178+22A>G | intron_variant | 2 | |||||
KIF5A | ENST00000674619.1 | c.445+22A>G | intron_variant | ||||||
KIF5A | ENST00000676457.1 | c.340+22A>G | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.425 AC: 64539AN: 151884Hom.: 14270 Cov.: 32
GnomAD3 genomes
AF:
AC:
64539
AN:
151884
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.469 AC: 117745AN: 251074Hom.: 29659 AF XY: 0.469 AC XY: 63632AN XY: 135694
GnomAD3 exomes
AF:
AC:
117745
AN:
251074
Hom.:
AF XY:
AC XY:
63632
AN XY:
135694
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.403 AC: 575124AN: 1425812Hom.: 123638 Cov.: 29 AF XY: 0.408 AC XY: 290600AN XY: 711536
GnomAD4 exome
AF:
AC:
575124
AN:
1425812
Hom.:
Cov.:
29
AF XY:
AC XY:
290600
AN XY:
711536
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.425 AC: 64632AN: 152002Hom.: 14309 Cov.: 32 AF XY: 0.437 AC XY: 32493AN XY: 74290
GnomAD4 genome
AF:
AC:
64632
AN:
152002
Hom.:
Cov.:
32
AF XY:
AC XY:
32493
AN XY:
74290
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2285
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 14, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Myoclonus, intractable, neonatal Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 19, 2021 | - - |
Hereditary spastic paraplegia 10 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 19, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at